Study guide

2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities

MRCP UK

Track your progress as you read

Finished sections get a check mark.

1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy

1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique

2 Clinical Sciences: Cellular, Genetic & Molecular Medicine

2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders

3 Clinical Sciences: Anatomy, Physiology & Immunology

3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions

4 Clinical Sciences: Statistics, Epidemiology & Trial Design

4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification

5 Clinical Pharmacology, Therapeutics & Toxicology

5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols

6 Cardiology: Coronary Artery Disease & Heart Failure

6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation

7 Cardiology: Arrhythmias, Valvular & Pericardial Disease

7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases

8 Respiratory Medicine: Airway & Parenchymal Lung Disease

8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis

9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders

9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing

10 Gastroenterology: Luminal Gastrointestinal Disease

10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia

11 Gastroenterology: Liver, Biliary & Pancreatic Disease

11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis

12 Endocrinology & Diabetes: Diabetes & Thyroid

12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules

13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium

13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease

14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease

14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases

15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance

15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis

16 Neurology: Cerebrovascular, Headache & Demyelinating Disease

16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases

17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease

17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders

18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease

18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies

19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy

19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease

20 Infectious Diseases & Tropical Medicine

20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites

21 Haematology: Anaemias & Red Cell Disorders

21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease

22 Haematology: Malignancy, Coagulation & Transfusion Medicine

22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions

23 Psychiatry in General Medicine

23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law

24 Geriatric Medicine

24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers

25 Dermatology

25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy

26 Oncology & Palliative Medicine

26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control

27 Medical Ophthalmology

27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease

2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities

Key Takeaways Explain This Topic AI

Myotonic dystrophy type 1 is a CTG expansion in DMPK, shows anticipation, and the congenital form is almost always maternally transmitted.

Huntington disease is a CAG expansion in HTT with paternal anticipation; Friedreich ataxia is a GAA expansion and is the exception that does not show anticipation.

Turner syndrome (45,X) is associated with bicuspid aortic valve and coarctation, and Klinefelter syndrome (47,XXY) with tall stature, gynaecomastia and hypergonadotrophic hypogonadism.

Last updated: September 2026

Dynamic Trinucleotide Repeat Expansions & Anticipation

Trinucleotide repeat disorders are caused by unstable tandem repeat expansions. During meiosis or mitotic replication, the repetitive tract slips, leading to hairpin loop formation during Okazaki fragment synthesis on the lagging strand, expanding the repeat length.

Genetic Anticipation : Disease manifests at an increasingly younger age and with progressively greater clinical severity in subsequent generations as the repeat length expands.

Parental Transmission Bias : Huntington disease expands most dramatically during paternal spermatogenesis , whereas Myotonic Dystrophy and Fragile X syndrome expand most extensively during maternal oogenesis .

Condition Repeat Sequence Gene & Chromosome Location & Molecular Consequence Anticipation Bias & Hallmark Manifestations

Fragile X Syndrome CGG FMR1 (Xq27.3) 5' UTR; >200 repeats triggers DNA hypermethylation and gene silencing Maternal expansion; post-pubertal macroorchidism, long face, large everted ears, autistic features; premutation (55-200) causes FXTAS/FXPOI

Huntington Disease CAG HTT (4p16.3) Coding exon 1; polyglutamine tract causes toxic gain-of-function Paternal expansion; chorea, progressive dementia, caudate nucleus atrophy, depression; full penetrance >40 repeats

Myotonic Dystrophy Type 1 CTG DMPK (19q13.3) 3' UTR; mutant RNA foci sequester MBNL1 splicing factor Maternal expansion; grip/percussion myotonia, Christmas-tree cataracts, cardiac conduction block, testicular atrophy

Friedreich Ataxia GAA FXN (9q21.1) Intron 1 ; heterochromatin formation silences frataxin Autosomal Recessive ; sensory/cerebellar ataxia, loss of vibration/proprioception, absent reflexes, hypertrophic cardiomyopathy, diabetes

Tip

High-Yield Distinction: Friedreich Ataxia vs Other Repeat Disorders :

Friedreich ataxia is the only common trinucleotide repeat disorder inherited in an autosomal recessive fashion . Because both alleles must harbor pathogenic mutations, it does not demonstrate the intergenerational anticipation seen in dominant pedigrees. Intronic GAA expansion impairs transcription of frataxin , a mitochondrial iron-chaperone protein. Mitochondrial iron overload generates reactive oxygen species, destroying the posterior columns, corticospinal tracts, and spinocerebellar tracts, accompanied by hypertrophic cardiomyopathy (the leading cause of premature death).

Constitutional Chromosomal Aneuploidies & Translocations

Aneuploidy refers to an abnormal chromosome number that is not an exact multiple of the haploid number (23). It stems predominantly from meiotic nondisjunction , where homologous chromosomes (Meiosis I) or sister chromatids (Meiosis II) fail to separate. The incidence of meiotic nondisjunction correlates directly with advanced maternal age . Meiotic Nondisjunction Outcomes

  • Meiosis I Failure ──> All gametes abnormal (50% Disomic [Trisomy after fertilisation], 50% Nullisomic)
  • Meiosis II Failure ──> 50% normal gametes, 25% Disomic (Trisomy), 25% Nullisomic (Monosomy)
  • Autosomal Trisomies

Down Syndrome (Trisomy 21; 47,XX/XY,+21) :

Etiology : 95% meiotic nondisjunction (predominantly maternal Meiosis I); 4% unbalanced Robertsonian translocation (e.g., der(14;21)); 1% post-zygotic mitotic mosaicism.

Craniofacial and Physical Features : Brachycephaly, flat occiput, epicanthic folds, upslanting palpebral fissures, Brushfield spots (white speckles on the iris perimeter), single transverse palmar crease (simian crease), sandal gap between 1st and 2nd toes.

Structural Anomalies : Complete atrioventricular septal defect (AVSD / endocardial cushion defect, 40%) , ventricular septal defect (VSD); gastrointestinal malformations including duodenal atresia ("double-bubble" sign on abdominal radiograph) and Hirschsprung disease.

Medical Complications : Early-onset Alzheimer's disease developing by age 40 (caused by triplication of the APP amyloid precursor protein gene on chromosome 21); acute lymphoblastic leukaemia (ALL, 20-fold increased risk) and acute megakaryoblastic leukaemia (AML-M7); coeliac disease, atlantoaxial instability, and hypothyroidism.

Edwards Syndrome (Trisomy 18; 47,XX/XY,+18) :

Micrognathia, prominent occiput, low-set malformed faun-like ears, clenched fists with overlapping fingers (2nd over 3rd, 5th over 4th), rocker-bottom feet (prominent calcaneus), congenital heart disease (VSD, patent ductus arteriosus), severe developmental delay; <10% survive beyond 1 year.

Patau Syndrome (Trisomy 13; 47,XX/XY,+13) :

Defective prechordal mesoderm development causing midline defects: holoprosencephaly , microphthalmia, cleft lip and palate, postaxial polydactyly , aplasia cutis congenita (focal punched-out scalp ulcerations), cystic renal dysplasia; median survival <7 days.

Sex Chromosome Aneuploidies

Turner Syndrome (45,X) :

Complete or partial absence of the second sex chromosome (50% 45,X; 20-30% mosaicism 45,X/46,XX; 10% isochromosome Xq [46,X,i(Xq)]).

Clinical Manifestations : Short stature (caused by haploinsufficiency of the SHOX gene in the pseudoautosomal region); ovarian dysgenesis with "streak ovaries" producing hypergonadotrophic hypogonadism (elevated FSH and LH, low oestrogen) and primary amenorrhoea; webbed neck (cystic hygroma due to lymphatic hypoplasia), low posterior hairline, shield chest with widely spaced nipples, and cubitus valgus.

Cardiovascular & Renal : Bicuspid aortic valve (30%) , coarctation of the aorta (10%) , and aortic root dilatation conferring elevated lifetime risk of aortic dissection. Renal anomalies include horseshoe kidney (which becomes trapped beneath the inferior mesenteric artery during embryogenesis). Intellect is typically normal.

Klinefelter Syndrome (47,XXY) :

Presence of one or more extra X chromosomes in a male phenotype due to parental meiotic nondisjunction.

Clinical Manifestations : Tall stature with eunuchoid proportions (increased leg length, decreased upper-to-lower segment ratio); primary testicular failure with small, firm, fibrotic testes (hyalinisation of seminiferous tubules); hypergonadotrophic hypogonadism (elevated LH/FSH, low testosterone) resulting in delayed puberty, sparse facial/body hair, and azoospermia/infertility; bilateral gynaecomastia .

Malignancy Risks : 20- to 50-fold increased risk of male breast cancer ; increased risk of extragonadal mediastinal germ cell tumors and non-Hodgkin lymphoma; osteoporosis.

Robertsonian Translocations

Robertsonian translocations occur exclusively between the five acrocentric chromosomes : 13, 14, 15, 21, and 22 . These chromosomes possess very short p-arms composed entirely of repetitive ribosomal RNA (rRNA) gene clusters.

Mechanism : Breaks occur near the centromeres, with fusion of the long arms (q) to form a single derivative metacentric chromosome, and loss of the tiny short arms (p). Because rRNA gene clusters are reiterated on the remaining acrocentric chromosomes, loss of the p-arms produces no phenotypic consequence.

Balanced Carrier : A balanced carrier has 45 chromosomes (e.g., 45,XX,der(14;21)(q10;q10)) and is clinically asymptomatic.

Reproductive Risks : During meiosis, the derivative chromosome and its homologues pair as a trivalent. Alternate segregation yields normal or balanced carrier gametes. Adjacent segregation produces unbalanced gametes (monosomy 14, trisomy 14, monosomy 21, or trisomy 21). When a female carrier of a der(14;21) conceives, the empirical risk of having a live-born child with translocation Down syndrome (46,XX,+21,der(14;21)) is approximately 10-15% (compared to 1-2% if the father is the carrier, due to selective loss of unbalanced sperm). If a carrier harbors a homologous der(21;21) translocation, 100% of viable pregnancies will result in Down syndrome .